Literature DB >> 25829995

The effect of low-dose intravenous ketamine on postoperative pain following cesarean section with spinal anesthesia: a randomized clinical trial.

Mojgan Rahmanian1, Mehri Leysi1, Ali Akbar Hemmati2, Majid Mirmohammadkhani3.   

Abstract

OBJECTIVES: Low-dose ketamine has been considered a good substitute for opioids for controlling postoperative pain. The purpose of this study was to determine the effect of low-dose intravenous ketamine following cesarean section with spinal anesthesia on postoperative pain and its potential complications.
METHODS: One hundred and sixty pregnant women volunteered to participate in this randomized controlled trial. Participants were randomly divided into two groups (n=80 for each group). Five minutes after delivery, the experimental group received 0.25mg/kg ketamine while the control group received the same amount of normal saline.
RESULTS: There was a significant difference between the two groups in the severity of pain at one, two, six, and 12 hours following surgery. Postoperative pain was significantly less severe in the experimental group. Compared to the control group, the experimental group felt pain less frequently and therefore asked for analgesics less often. On average, the number of doses of analgesics used for the participants in the experimental group was significantly less than the number of doses used for the control group. Analgesic side effects (including nausea, itching, and headache) were not significantly different between the two groups. However, vomiting was significantly more prevalent in the control group and hallucination was more common in the experimental group.
CONCLUSION: We conclude that administration of low doses of ketamine after spinal anesthesia reduces the need for analgesics and has fewer side effects than using opioids. Further studies are required to determine the proper dose of ketamine which offers maximum analgesic effect. Furthermore, administration of low-dose ketamine in combination with other medications in order to minimize its side effects warrants further investigation.

Entities:  

Keywords:  Anesthesia, Spinal; Cesarean Section; Ketamine; Pain, Postoperative

Year:  2015        PMID: 25829995      PMCID: PMC4371456          DOI: 10.5001/omj.2015.03

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  14 in total

1.  Quality of life after cesarean and vaginal delivery.

Authors:  Seyed Abbas Mousavi; Forough Mortazavi; Reza Chaman; Ahmad Khosravi
Journal:  Oman Med J       Date:  2013-07

2.  Low-dose ketamine with multimodal postcesarean delivery analgesia: a randomized controlled trial.

Authors:  J R Bauchat; N Higgins; K G Wojciechowski; R J McCarthy; P Toledo; C A Wong
Journal:  Int J Obstet Anesth       Date:  2011-01       Impact factor: 2.603

3.  The persisting analgesic effect of low-dose intravenous ketamine after spinal anaesthesia for caesarean section.

Authors:  S Sen; G Ozmert; O N Aydin; N Baran; E Caliskan
Journal:  Eur J Anaesthesiol       Date:  2005-07       Impact factor: 4.330

4.  Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review.

Authors:  B Walder; M Schafer; I Henzi; M R Tramèr
Journal:  Acta Anaesthesiol Scand       Date:  2001-08       Impact factor: 2.105

Review 5.  Ketamine for perioperative pain management in children: a meta-analysis of published studies.

Authors:  Souhayl Dahmani; Daphné Michelet; Paer-Selim Abback; Chantal Wood; Christopher Brasher; Yves Nivoche; Jean Mantz
Journal:  Paediatr Anaesth       Date:  2011-03-29       Impact factor: 2.556

Review 6.  Preemptive analgesia I: physiological pathways and pharmacological modalities.

Authors:  D J Kelly; M Ahmad; S J Brull
Journal:  Can J Anaesth       Date:  2001-11       Impact factor: 5.063

7.  Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia.

Authors:  S Kathirvel; S Sadhasivam; A Saxena; T R Kannan; P Ganjoo
Journal:  Anaesthesia       Date:  2000-09       Impact factor: 6.955

8.  Low-dose intravenous ketamine improves postoperative analgesia after caesarean delivery with spinal bupivacaine in African parturients.

Authors:  I D Menkiti; I Desalu; O T Kushimo
Journal:  Int J Obstet Anesth       Date:  2012-06-01       Impact factor: 2.603

Review 9.  Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration.

Authors:  Robert H Kronenberg
Journal:  J Pain Palliat Care Pharmacother       Date:  2002

10.  Small-dose ketamine infusion improves postoperative analgesia and rehabilitation after total knee arthroplasty.

Authors:  Frédéric Adam; Marcel Chauvin; Bertrand Du Manoir; Mathieu Langlois; Daniel I Sessler; Dominique Fletcher
Journal:  Anesth Analg       Date:  2005-02       Impact factor: 6.627

View more
  5 in total

Review 1.  Post-caesarean analgesia: What is new?

Authors:  Sukhyanti Kerai; Kirti Nath Saxena; Bharti Taneja
Journal:  Indian J Anaesth       Date:  2017-03

2.  PROSPECT guideline for elective caesarean section: updated systematic review and procedure-specific postoperative pain management recommendations.

Authors:  E Roofthooft; G P Joshi; N Rawal; M Van de Velde
Journal:  Anaesthesia       Date:  2020-12-28       Impact factor: 12.893

3.  Effect of low-dose intravenous ketamine on postoperative pain following cesarean section under spinal anesthesia: A prospective cohort study, Ethiopia.

Authors:  Hirbo Samuel; Senait Aweke; Jemal Tuni
Journal:  Ann Med Surg (Lond)       Date:  2022-04-03

Review 4.  Effect of Intravenous Ketamine on Hypocranial Pressure Symptoms in Patients with Spinal Anesthetic Cesarean Sections: A Systematic Review and Meta-Analysis.

Authors:  Xiaoshen Liang; Xin Yang; Shuang Liang; Yu Zhang; Zhuofeng Ding; Qulian Guo; Changsheng Huang
Journal:  J Clin Med       Date:  2022-07-16       Impact factor: 4.964

5.  Efficacy and safety of wound infiltration modalities for postoperative pain management after cesarean section: a systematic review and network meta-analysis protocol.

Authors:  Semagn Mekonnen Abate; Getachew Mergia; Solomon Nega; Bivash Basu; Moges Tadesse
Journal:  Syst Rev       Date:  2022-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.